Skip to main content
Equibles
CRVS $12.91 -0.23%
CRVS logo
CRVS · Corvus Pharmaceuticals, Inc.
Track CRVS — free

Use CRVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.91 -0.03 (-0.23%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$1.09B
Shares
84.12M
All earnings calls

Earnings call · FY2024 Q2

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2024 Earnings Call

Concluded Aug 6, 2024
Aug 6, 2024 0 turns
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Diluted EPS -$0.07
Net income -$4.26M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 6, 2024 10-Q report Filed Aug 6, 2024

Forward guidance

From the 8-K filed Aug 6, 2024.

Metric Guided
Net cash used in operating activities Initiated
full year 2024
 $24M – $27M
Full-screen source Call document

CRVS transcript alerts

Corvus Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →